Carlsbad, CA — February 11, 2026 — Leads & Copy — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) will host a live webcast on Wednesday, February 25 at 11:30 a.m. Eastern Time to discuss its fourth quarter and full year 2025 financial results and highlight progress on key programs.
The webcast can be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
For three decades, Ionis has been inventing medicines for people with serious diseases. The company currently has marketed medicines and a pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies and is advancing new approaches in gene editing.
To learn more about Ionis, visit Ionis.com and follow them on X (Twitter), LinkedIn and Instagram.
Source: Ionis Pharmaceuticals, Inc.
